Publications by authors named "Nigel A Scott"

Claim this Profile
P
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB design.
Ekaterina V Kurbatova, Kelly E Dooley, Wendy Carr, Jason E Stout, Eric L Nuermberger, Nigel A Scott

Contemp Clin Trials· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes.
Ekaterina V Kurbatova, William C Whitworth, Lakshmi Praveena Peddareddy, Patrick P J Phillips, Nigel A Scott

Emerg Infect Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis.
Nicholas Winters, Robert Belknap, Andrea Benedetti, Andrey Borisov, Jonathon R Campbell, Nigel A Scott

Lancet Respir Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection.
Claire Sadowski, Robert Belknap, David P Holland, Ruth N Moro, Michael P Chen, Nigel A Scott

Clin Infect Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine.
Nigel A Scott, Claire Sadowski, Andrew Vernon, Bert Arevalo, Karlyn Beer

Contemp Clin Trials· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.
Ekaterina V Kurbatova, Patrick P J Phillips, Susan E Dorman, Erin E Sizemore, Kia E Bryant, Nigel A Scott

Am J Respir Crit Care Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing drug inventory management with a web-based information system: The TBTC Study 31/ACTG A5349 experience.
Nigel A Scott, Kara K Lee, Claire Sadowski, Ekaterina V Kurbatova, Stefan V Goldberg

Contemp Clin Trials· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, Patrick P J Phillips, Kia Bryant, Nigel A Scott

N Engl J Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2-Associated Deaths Among Persons Aged <21 Years - United States, February 12-July 31, 2020.
Danae Bixler, Allison D Miller, Claire P Mattison, Burnestine Taylor, Kenneth Komatsu, Nigel A Scott

MMWR Morb Mortal Wkly Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial.
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, Stefan V Goldberg, Lorna Bozeman, Nigel A Scott

Contemp Clin Trials· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonparticipation reasons in a randomized international trial of a new latent tuberculosis infection regimen.
Kimberley N Chapman Hedges, Andrey S Borisov, Jussi J Saukkonen, Nigel A Scott, Emily J Hecker

Clin Trials· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials.
Ruth N Moro, Nigel A Scott, Andrew Vernon, Naomi K Tepper, Stefan V Goldberg

Ann Am Thorac Soc· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.
Robert Belknap, David Holland, Pei-Jean Feng, Joan-Pau Millet, Joan A Caylà, Nigel A Scott

Ann Intern Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loop ileostomy-mediated fecal stream diversion is associated with microbial dysbiosis.
Emma L Beamish, Judith Johnson, Elisabeth J Shaw, Nigel A Scott, Arnab Bhowmick

Gut Microbes· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada.
Ruth N Moro, Andrey S Borisov, Jussi Saukkonen, Awal Khan, Timothy R Sterling, Nigel A Scott

Clin Infect Dis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.
Timothy R Sterling, Nigel A Scott, Jose M Miro, Guilherme Calvet, Alberto La Rosa

AIDS· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.
M Elsa Villarino, Nigel A Scott, Stephen E Weis, Marc Weiner, Marcus B Conde

JAMA Pediatr· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis Infection.
Marc Weiner, Radojka M Savic, William R Mac Kenzie, Diane Wing, Charles A Peloquin, Nigel A Scott

J Pediatric Infect Dis Soc· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of reconstructive surgery for intestinal fistula in the open abdomen.
Patrick T Connolly, Antje Teubner, Nicholas P Lees, Iain D Anderson, Nigel A Scott

Ann Surg· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis